Literature DB >> 7012019

Role of thymus for N-acetyl muramyl-L-alanyl-D-isoglutamine-induced polyarthritis and granuloma formation in euthymic and athymic nude rats or in neonatally thymectomized rats.

O Kohashi, C M Pearson, N Tamaoki, A Tanaka, K Shimamura, A Ozawa, S Kotani, M Saito, K Hioki.   

Abstract

A synthetic adjuvant, N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), produced extremely severe polyarthritis with almost 100% incidence in Rowett euthymic rnu/+ rats, but the same dose of MDP (100 microgram) did not produce the disease in athymic rnu/rnu rats. Five hundred micrograms of MDP or 0.2 mg of heat-killed Mycobacterium bovis BCG, however, produced mild and transient polyarthritis in nude rats with very low incidence. We have not yet succeeded in reconstituting the disease susceptibility of nude rats by using thymus cells from normal rnu/+ rats. After intradermal inoculation of 100 microgram of MDP, nude rats developed small granulomas with a little necrosis and very few multinucleated giant cells only in the regional lymph nodes, whereas, in addition to the development of polyarthritis, euthymic rnu/+ rats developed typical granuloma with massive necrosis accompanied by numerous polymorphonuclear leukocytes and sparse multinucleated giant cells in the regional lymph nodes. Thymus cell-reconstituted rnu/rnu rats developed granuloma with sparse giant cells, relatively large areas of necrosis, and many polymorphonuclear leukocytes. Neonatal thymectomy may depress adjuvant-induced arthritis in the high-responder Lewis rats and enhance the disease development in the low-responder F344 rats. These findings suggested that (i) thymus plays an important role in promoting the development of MDP-induced arthritis; (ii) MDP-induced granuloma formation does not require thymus functions; (iii) the thymus functions may however be involved in the development of massive necrosis surrounded by considerable polymorphonuclear leukocyte infiltration, the mechanisms of which remain to be determined; and (iv) there is no direct correlation between granuloma formation and development of adjuvant arthritis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7012019      PMCID: PMC351375          DOI: 10.1128/iai.31.2.758-766.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Immunopathology of schistosomiasis in athymic mice.

Authors:  C K Hsu; S H Hsu; R A Whitney; C T Hansen
Journal:  Nature       Date:  1976-07-29       Impact factor: 49.962

2.  PASSIVE TRANSFER OF ADJUVANT ARTHRITIS BY LYMPH NODE OR SPLEEN CELLS.

Authors:  C M PEARSON; F D WOOD
Journal:  J Exp Med       Date:  1964-10-01       Impact factor: 14.307

3.  Identification and separation of pre T-cells from nu/nu mice: differentiation by preculture with thymic reticuloepithelial cells.

Authors:  V L Sato; S D Waksal; L A Herzenberg
Journal:  Cell Immunol       Date:  1976-06-01       Impact factor: 4.868

4.  [On the chemical constitution of an antigenic lipo-polysaccharide extract of Mycobacterium tuberculosis var. hominis].

Authors:  J ASSELINEAU; N CHOUCROUN; E LEDERER
Journal:  Biochim Biophys Acta       Date:  1950-04

5.  Correlation of stereochemically specific structure in muramyl dipeptide between macrophage activation and adjuvant activity.

Authors:  A Tanaka; S Nagao; R Saito; S Kotani; S Kusumoto; T Shiba
Journal:  Biochem Biophys Res Commun       Date:  1977-07-25       Impact factor: 3.575

6.  Passive transfer of adjuvant-induced arthritis and allergic encephalomyelitis in rats using thoracic duct lymphocytes.

Authors:  D J Whitehouse; M W Whitehouse; C M Pearson
Journal:  Nature       Date:  1969-12-27       Impact factor: 49.962

7.  Competence of thoracic duct cells in the transfer of adjuvant disease and delayed hypersensitivity. Evidence that mycobacterial components are required for the successful transfer of the disease.

Authors:  F Quagliata; J M Phillips-Quagliata
Journal:  Cell Immunol       Date:  1972-01       Impact factor: 4.868

8.  Structural requirements for arthritogenicity of peptidoglycans from Staphylococcus aureus and Lactobacillus plant arum and analogous synthetic compounds.

Authors:  O Kohashi; C M Pearson; Y Watanabe; S Kotani; T Koga
Journal:  J Immunol       Date:  1976-06       Impact factor: 5.422

9.  Granuloma formation by synthetic bacterial cell wall fragment: muramyl dipeptide.

Authors:  K Emori; A Tanaka
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

10.  Suppression of adjuvant disease in the rat by heterologous antilymphocyte globulin.

Authors:  H L Currey; M Ziff
Journal:  J Exp Med       Date:  1968-01-01       Impact factor: 14.307

View more
  6 in total

1.  Initiation and perpetuation of rat adjuvant arthritis is inhibited by the anti-CD2 monoclonal antibody (mAb) OX34.

Authors:  J C Hoffmann; C Herklotz; H Zeidler; B Bayer; H Rosenthal; J Westermann
Journal:  Ann Rheum Dis       Date:  1997-12       Impact factor: 19.103

2.  Cell migration studies in the adoptive transfer of adjuvant arthritis in the Lewis rat.

Authors:  A G Van de Langerijt; S G Volsen; C A Hicks; P J Craig; M E Billingham; W B Van den Berg
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

3.  Arthritogenic activity of a synthetic immunoadjuvant, muramyl dipeptide.

Authors:  Z Zídek; K Maśek; Z Jiricka
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

4.  Role of the thymus in streptococcal cell wall-induced arthritis and hepatic granuloma formation. Comparative studies of pathology and cell wall distribution in athymic and euthymic rats.

Authors:  J B Allen; D G Malone; S M Wahl; G B Calandra; R L Wilder
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

5.  Differential effects of methotrexate and liposomally conjugated methotrexate in rat adjuvant-induced arthritis.

Authors:  A S Williams; J P Camilleri; N Amos; B D Williams
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

6.  Differences in proinflammatory activity of several immunomodulatory derivatives of muramyl dipeptide (MDP) with special reference to the mechanism of the MDP effects.

Authors:  Z Zídek
Journal:  Agents Actions       Date:  1992-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.